Marizyme Stock Buy Hold or Sell Recommendation
| MRZM Stock | USD 0 0 66.67% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Marizyme is 'Strong Sell'. The recommendation algorithm takes into account all of Marizyme's available fundamental, technical, and predictive indicators you will find on this site.
Check out Marizyme Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Marizyme and provide practical buy, sell, or hold advice based on investors' constraints. Marizyme. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Marizyme |
Execute Marizyme Buy or Sell Advice
The Marizyme recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Marizyme. Macroaxis does not own or have any residual interests in Marizyme or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Marizyme's advice using the current market data and latest reported fundamentals.
Time Horizon
3 Months |
Risk Tolerance
I am an educated risk taker |
 |  |
Strong Sell
Market Performance | OK | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Marizyme Trading Alerts and Improvement Suggestions
| Marizyme is way too risky over 90 days horizon | |
| Marizyme has some characteristics of a very speculative penny stock | |
| Marizyme appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 210.28 K. Net Loss for the year was (11 M) with profit before overhead, payroll, taxes, and interest of 129.93 K. | |
| Marizyme currently holds about 2.04 M in cash with (5.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Marizyme Returns Distribution Density
The distribution of Marizyme's historical returns is an attempt to chart the uncertainty of Marizyme's future price movements. The chart of the probability distribution of Marizyme daily returns describes the distribution of returns around its average expected value. We use Marizyme price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Marizyme returns is essential to provide solid investment advice for Marizyme.
| Mean Return | 13.62 |
| Value At Risk | -18 |
| Potential Upside | 0.00 |
| Standard Deviation | 50.15 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Marizyme historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Marizyme Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Marizyme or Software sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Marizyme's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Marizyme pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 10.32 | |
β | Beta against Dow Jones | -30.21 | |
σ | Overall volatility | 128.49 | |
Ir | Information ratio | 0.11 |
Marizyme Volatility Alert
Marizyme is showing large volatility of returns over the selected time horizon. Marizyme is a penny stock. Even though Marizyme may be a good instrument to invest, many penny pink sheets are speculative instruments that are subject to artificial stock promotions. Please make sure you fully understand upside and downside scenarios of investing in Marizyme or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings,sudden promotions and many other similar artificial hype indicators. We also encourage traders to check work history of company executives before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Marizyme instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Marizyme Fundamentals Vs Peers
Comparing Marizyme's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Marizyme's direct or indirect competition across all of the common fundamentals between Marizyme and the related equities. This way, we can detect undervalued stocks with similar characteristics as Marizyme or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Marizyme's fundamental indicators could also be used in its relative valuation, which is a method of valuing Marizyme by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Marizyme to competition |
| Fundamentals | Marizyme | Peer Average |
| Return On Equity | -0.5 | -0.31 |
| Return On Asset | -0.15 | -0.14 |
| Operating Margin | (180.85) % | (5.51) % |
| Current Valuation | 17.35 M | 16.62 B |
| Shares Outstanding | 10.13 M | 571.82 M |
| Shares Owned By Insiders | 2.04 % | 10.09 % |
| Price To Book | 0.37 X | 9.51 X |
| Price To Sales | 133.06 X | 11.42 X |
| Revenue | 210.28 K | 9.43 B |
| Gross Profit | 129.93 K | 27.38 B |
| EBITDA | (10.83 M) | 3.9 B |
| Net Income | (11 M) | 570.98 M |
| Cash And Equivalents | 2.04 M | 2.7 B |
| Cash Per Share | 0.05 X | 5.01 X |
| Total Debt | 495.32 K | 5.32 B |
| Debt To Equity | 0.07 % | 48.70 % |
| Current Ratio | 1.74 X | 2.16 X |
| Book Value Per Share | 1.00 X | 1.93 K |
| Cash Flow From Operations | (5.79 M) | 971.22 M |
| Earnings Per Share | (0.39) X | 3.12 X |
| Number Of Employees | 11 | 18.84 K |
| Beta | 0.36 | -0.15 |
| Market Capitalization | 5.07 M | 19.03 B |
| Total Asset | 66 M | 29.47 B |
| Z Score | 6.0 | 8.72 |
| Net Asset | 66 M |
Marizyme Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Marizyme . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.67 | |||
| Day Median Price | 0.003 | |||
| Day Typical Price | 0.003 | |||
| Price Action Indicator | 6.0E-4 | |||
| Period Momentum Indicator | 0.0012 | |||
| Relative Strength Index | 53.55 |
About Marizyme Buy or Sell Advice
When is the right time to buy or sell Marizyme? Buying financial instruments such as Marizyme Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Marizyme in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Equity ETFs Thematic Idea Now
Broad Equity ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Equity ETFs theme has 490 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Equity ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Marizyme Pink Sheet
Marizyme financial ratios help investors to determine whether Marizyme Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Marizyme with respect to the benefits of owning Marizyme security.